During viral packaging, the sCAR-ligand fusion protein would be expressed in packaging cells and non-covalently installed on viral surface, bridging oncolytic adenoviruses to CD123+ or CD47+ leukemia cells. The gene discussed is CD47; the disease is leukemia.